tiprankstipranks
Trending News
More News >
Cherish Sunshine International Limited (HK:1094)
:1094
Hong Kong Market

Cherish Sunshine International Limited (1094) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1094

Cherish Sunshine International Limited

(1094)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
,
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
HK$0.42
▲(10.79% Upside)
Action:ReiteratedDate:03/12/26
The score is held down primarily by weak financial performance, including a steep revenue drop and ongoing losses, despite improved free cash flow. Technicals are moderately supportive with price above major moving averages and a positive MACD, but an elevated RSI indicates stretched momentum. Valuation remains unattractive/uncertain due to a negative P/E and no dividend yield data.
Positive Factors
Free cash flow improvement
A nearly tenfold jump in free cash flow and a FCF-to-net-income ratio near 1 indicate the company can convert accounting losses into cash. That durable cash-generation improvement supports liquidity, debt service, and selective reinvestment or restructuring over the next several quarters.
Manageable leverage
A moderate debt-to-equity ratio around 0.84 implies the company is not excessively levered. Combined with stronger free cash flow, this provides financial flexibility to refinance or service obligations without immediate distress, preserving operational options over a multi-quarter horizon.
Stable equity base
Presence of a reasonable equity cushion, as noted in the balance sheet summary, provides a buffer against continuing losses. This structural stability helps absorb shocks, retain creditor confidence, and supports the ability to raise capital or execute strategic pivots over the medium term.
Negative Factors
Severe revenue decline
An 85% revenue collapse signals a structural hit to demand, contracts, or product relevance. Such a steep drop undermines scale economies and customer relationships, making margin recovery and sustainable growth difficult without clear strategic changes or new revenue streams.
Ongoing negative margins
Sustained negative EBIT and net margins indicate the core business is unprofitable, eroding capital and limiting reinvestment. Persistent operating losses constrain long-term competitiveness and may necessitate dilutive financing, cost cuts, or asset sales to restore viability.
Earnings collapse and negative ROE
A catastrophic EPS decline and negative ROE show past losses have severely reduced shareholder returns and equity productivity. This harms the company’s ability to attract equity capital and weakens investor confidence, limiting strategic options over the medium term.

Cherish Sunshine International Limited (1094) vs. iShares MSCI Hong Kong ETF (EWH)

Cherish Sunshine International Limited Business Overview & Revenue Model

Company DescriptionChina Public Procurement Limited, an investment holding company, engages in the trading of various products in the People's Republic of China. It operates through five segments: Provision of Procurement Services, Trading Business, Provision of Corporate IT Solution, Rental Income, Energy Management Contracting Business. The company is involved in the provision of procurement services to governmental authorities, and private enterprises; and provides energy management contracting services. It also engages in the leasing of investment properties; and trades in various products. In addition, the company develops software and provides maintenance services. The company was formerly known as Sunny Global Holdings Limited and changed its name to China Public Procurement Limited in May 2009. China Public Procurement Limited was incorporated in 2002 and is headquartered in Hangzhou, Hong Kong.

Cherish Sunshine International Limited Financial Statement Overview

Summary
Financials are pressured by an 85.15% revenue decline and negative net/EBIT margins, indicating ongoing losses and unstable operations. Balance sheet leverage is moderate (debt-to-equity 0.84) but ROE is negative. Cash flow is a relative bright spot with sharply higher free cash flow (+968.47%) and strong FCF-to-net income (0.99), though operating cash flow vs. net income is low (0.14).
Income Statement
20
Very Negative
The income statement reveals significant challenges, with a drastic revenue decline of 85.15% in the latest period. The company has negative net and EBIT margins, indicating substantial losses. The gross profit margin is relatively low at 28.68%, and the revenue growth trajectory has been inconsistent over the years, reflecting volatility in the company's operations.
Balance Sheet
45
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.84, suggesting manageable leverage. However, the return on equity is negative, indicating that the company is not generating profits from its equity base. The equity ratio is not explicitly provided, but the overall financial health appears stable with a reasonable level of equity compared to assets.
Cash Flow
60
Neutral
Cash flow analysis highlights a remarkable improvement in free cash flow growth, up by 968.47%. The operating cash flow to net income ratio is low at 0.14, suggesting limited cash generation relative to net income. However, the free cash flow to net income ratio is strong at 0.99, indicating efficient cash conversion from earnings.
BreakdownTTMMar 2024Mar 2023Mar 2023Dec 2021Dec 2020
Income Statement
Total Revenue49.07M98.25M782.18M271.72M112.20M93.56M
Gross Profit16.76M28.18M59.51M37.63M19.38M18.61M
EBITDA-103.47M-129.58M-1.38M3.12M-27.94M-4.21M
Net Income-159.16M-123.89M656.00K13.28M-25.54M1.64M
Balance Sheet
Total Assets508.06M538.01M727.93M593.42M369.22M360.00M
Cash, Cash Equivalents and Short-Term Investments21.69M30.53M6.31M8.48M27.59M17.66M
Total Debt173.88M171.97M124.11M137.96M26.94M34.74M
Total Liabilities341.85M344.97M432.62M283.06M174.56M155.53M
Stockholders Equity177.44M204.72M307.00M321.87M206.91M214.38M
Cash Flow
Free Cash Flow-28.20M45.92M11.80M-222.47M-25.67M1.22M
Operating Cash Flow-28.01M46.11M12.58M-217.05M-25.13M1.61M
Investing Cash Flow-10.63M-95.33M-146.00K-764.00K1.03M-6.09M
Financing Cash Flow7.45M62.45M-14.40M200.86M33.98M-2.99M

Cherish Sunshine International Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.38
Price Trends
50DMA
0.36
Positive
100DMA
0.36
Positive
200DMA
0.45
Positive
Market Momentum
MACD
0.03
Negative
RSI
65.22
Neutral
STOCH
36.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1094, the sentiment is Positive. The current price of 0.38 is below the 20-day moving average (MA) of 0.42, above the 50-day MA of 0.36, and below the 200-day MA of 0.45, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 65.22 is Neutral, neither overbought nor oversold. The STOCH value of 36.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1094.

Cherish Sunshine International Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
51
Neutral
HK$395.94M-21.76-7.33%11.32%62.61%
50
Neutral
HK$171.52M26.190.74%-9.32%
49
Neutral
HK$261.45M-0.28-30.56%30.86%-67.89%
48
Neutral
HK$290.33M-2.06-66.52%-92.58%-44916.67%
41
Neutral
HK$535.00M-1.61-4.03%55.27%68.84%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1094
Cherish Sunshine International Limited
0.49
0.13
36.11%
HK:1222
Wang On Group Limited
0.02
0.00
0.00%
HK:1282
Glory Sun Financial Group Limited
0.11
0.01
11.46%
HK:0118
Cosmos Machinery Enterprises Limited
0.20
0.03
17.06%
HK:2700
Green International Holdings Limited
0.60
0.18
42.86%

Cherish Sunshine International Limited Corporate Events

Cherish Sunshine Revamps Board as CFO and INED Resign, New Independent Director Appointed
Mar 19, 2026

Cherish Sunshine International has announced a series of board and management changes effective 19 March 2026, including the resignation of executive director and chief financial officer Sze Kam Shing Alan, who will remain as company secretary and an authorised representative. Independent non-executive director Deng Hua has also resigned from the board and its key committees to focus on other business commitments.

To fill the independent oversight gap, the company has appointed finance veteran Wang Xiaoqiong as an independent non-executive director and member of the nomination, remuneration and audit committees on a three-year term. With over 15 years of finance and accounting experience across listed companies and a current role in medical biotechnology, Wang’s appointment is expected to strengthen the group’s governance structure and ensure continuity in board committee functions despite the recent departures.

The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.41 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.

Cherish Sunshine International Sets Out Board and Committee Structure
Mar 19, 2026

Cherish Sunshine International Limited has announced the composition of its board of directors, naming Yang Hua as executive director, joint chairman and chief executive, with Ng Siu Hong as non-executive director and three independent non-executive directors, Zhao Zhijiao, He Zhi and Wang Xiaoqiong, with Zhao also serving as joint chairman. The company also detailed the membership and chairmanship of its three key board committees, audit, remuneration and nomination, underscoring its corporate governance framework and the role of independent directors in overseeing financial reporting, pay and board appointments.

This latest board and committee lineup confirms the allocation of responsibilities among executive, non-executive and independent directors, which may enhance accountability and checks and balances within the organisation. By highlighting independent leadership of critical committees, Cherish Sunshine International signals continued adherence to governance norms expected of Hong Kong listed companies, which is relevant for investors monitoring oversight quality and board independence.

The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.41 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.

Cherish Sunshine Drops Photovoltaic Inverter Joint Venture After PRC Policy Shift
Jan 16, 2026

Cherish Sunshine International Limited has terminated a previously announced plan to form a joint venture with Xinhui Yuanheng to invest in the photovoltaic inverter business in mainland China. Although the JV company had been incorporated, neither party had injected share capital, and, following recent changes in PRC policies affecting the photovoltaic industry in early January 2026, both sides agreed that launching the venture was no longer commercially justifiable and signed a termination agreement on 16 January 2026, with the JV to be deregistered. The board stated that ending the venture is not expected to have a material adverse impact on the group’s financial performance or operations and considers the decision to be in the overall interests of the company and its shareholders.

The most recent analyst rating on (HK:1094) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Cherish Sunshine International Limited stock, see the HK:1094 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026